Cingulate Inc (CING) Stock Price, Quote, News & History

CINGNASDAQ
$5.11
-0.06-1.16%
At close: Aug 31, 5:00 PM EST
$5.11
-0.06-1.16%
Pre-Market: 7:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-20.65M
Investing Cash Flow (TTM)
-284.48K
Financing Cash Flow (TTM)
40.44M
Free Cash Flow (TTM)
-20.94M
Capital Expenditure (TTM)
-284.48K
Net Change in Cash (TTM)
19.50M

Analyst Trends and Forecast

1
Mar
1
Apr
1
May
1
Jun
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$52.63M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.19
Earnings Yield % (TTM)
-69.26%
Earnings Yield % (FWD)
-32.10%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.61

Company Debt

Total Debt
$5.07M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$660.00K
Total Cash
$28.40M
Debt to Equity
0.27
Issuance of Debt (TTM)
$5.34M
Repayment of Debt (TTM)
-$660.00K

Key Statistics

Open
-
Close
$5.11
Volume / Avg.
1.21K / 356.46K
Day Range
- - -
52 Wk Range
3.16 - 11.89
Market Cap
$74.31M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
11.54%
Days to Cover
7.8

About

Sector
Health Care
Industry
Pharmaceuticals
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an ini...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cingulate (CING) stock?

A

You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cingulate (CING) competitors?

Q

What is the forecast, or price target, for Cingulate (CING) stock?

A

Cingulate has a consensus price target of $21.25.

Q

What is the current price for Cingulate (CING)?

A

The stock price for Cingulate (NASDAQ: CING) is $5.11 last updated September 2, 2026 at 7:00 AM EDT.

Q

Does Cingulate (CING) pay a dividend?

A

There are no upcoming dividends for Cingulate.

Q

When is Cingulate (NASDAQ:CING) reporting earnings?

A

Cingulate does not have any upcoming earnings scheduled.

Q

Is Cingulate (CING) going to split?

A

There is no upcoming split for Cingulate.

Q

What sector and industry does Cingulate (CING) operate in?

A

Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.